Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Assessment of Antiretroviral Treatment Adherence among Children Attending Care at a Tertiary Hospital in Southeastern Nigeria.

Akahara C, Nwolisa E, Odinaka K, Okolo S.

J Trop Med. 2017;2017:3605850. doi: 10.1155/2017/3605850. Epub 2017 Feb 5.

2.

Magnitude of cytopenias among HIV-infected children in Bahir Dar, northwest Ethiopia: a comparison of HAART-naïve and HAART-experienced children.

Tsegay YG, Tadele A, Addis Z, Alemu A, Melku M.

HIV AIDS (Auckl). 2017 Feb 20;9:31-42. doi: 10.2147/HIV.S125958. eCollection 2017.

3.

Assessing Adherence to Antiretroviral Therapy in a Rural Paediatric Cohort in KwaZulu-Natal, South Africa.

Smith C, Gengiah TN, Yende-Zuma N, Upfold M, Naidoo K.

AIDS Behav. 2016 Nov;20(11):2729-2738.

PMID:
27289369
4.

Predictors of loss to follow-up in antiretroviral treatment for adult patients in the Oromia region, Ethiopia.

Megerso A, Garoma S, Eticha T, Workineh T, Daba S, Tarekegn M, Habtamu Z.

HIV AIDS (Auckl). 2016 Apr 26;8:83-92. doi: 10.2147/HIV.S98137. eCollection 2016.

5.

Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.

Adejumo OA, Malee KM, Ryscavage P, Hunter SJ, Taiwo BO.

J Int AIDS Soc. 2015 Sep 16;18:20049. doi: 10.7448/IAS.18.1.20049. eCollection 2015. Review.

6.

Disclosure of their HIV status to perinatally infected youth using the adapted Blasini disclosure model in Haiti and the Dominican Republic: preliminary results.

Beck-Sagué CM, Dévieux J, Pinzón-Iregui MC, Lerebours-Nadal L, Abreu-Pérez R, Bertrand R, Rouzier V, Gaston S, Ibanez G, Halpern M, Pape JW, Dorceus P, Preston SM, Dean AG, Nicholas SW, Blasini I.

AIDS. 2015 Jun;29 Suppl 1:S91-8. doi: 10.1097/QAD.0000000000000665.

8.

Factors associated with antiretroviral treatment interruption in human immunodeficiency virus (HIV)-1-infected children attending the Jos University Teaching Hospital, Jos, Nigeria.

Ebonyi AO, Ejeliogu EU, Okpe SE, Shwe DD, Yiltok ES, Ochoga MO, Oguche S.

Niger Med J. 2015 Jan-Feb;56(1):43-7. doi: 10.4103/0300-1652.149170.

10.

Caregiver-reported adherence to antiretroviral therapy among HIV infected children in Mekelle, Ethiopia.

Eticha T, Berhane L.

BMC Pediatr. 2014 Apr 27;14:114. doi: 10.1186/1471-2431-14-114.

11.
12.

Decentralised paediatric HIV care in Ethiopia: a comparison between outcomes of patients managed in health centres and in a hospital clinic.

Hagströmer O, Lundstedt L, Balcha TT, Björkman P.

Glob Health Action. 2013 Nov 11;6:22274. doi: 10.3402/gha.v6i0.22274.

13.
14.
15.
16.

Factors associated with HIV/AIDS diagnostic disclosure to HIV infected children receiving HAART: a multi-center study in Addis Ababa, Ethiopia.

Biadgilign S, Deribew A, Amberbir A, Escudero HR, Deribe K.

PLoS One. 2011 Mar 21;6(3):e17572. doi: 10.1371/journal.pone.0017572.

17.

Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countries.

Peacock-Villada E, Richardson BA, John-Stewart GC.

Pediatrics. 2011 Feb;127(2):e423-41. doi: 10.1542/peds.2009-2701. Epub 2011 Jan 24. Review.

18.
19.

The perceived impact of disclosure of pediatric HIV status on pediatric antiretroviral therapy adherence, child well-being, and social relationships in a resource-limited setting.

Vreeman RC, Nyandiko WM, Ayaya SO, Walumbe EG, Marrero DG, Inui TS.

AIDS Patient Care STDS. 2010 Oct;24(10):639-49. doi: 10.1089/apc.2010.0079.

20.

Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat.

Webb KM, Aksenov MY, Mactutus CF, Booze RM.

J Neurovirol. 2010 Mar;16(2):168-73. doi: 10.3109/13550281003690177.

Supplemental Content

Support Center